Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : For    symbols : TEVJF    save search

Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Published: 2024-04-24 (Crawled : 08:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K twitter stocktwits trandingview |
n/a
| | O: 1.12% H: 1.48% C: -0.07%
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 0.0% C: 0.0%

avt05 simponi biosimilar for topline results study
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published: 2024-04-19 (Crawled : 10:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K twitter stocktwits trandingview |
n/a
| | O: 1.16% H: 7.28% C: 1.3%
KMDA | $5.16 1.18% 1.16% 11K twitter stocktwits trandingview |
Health Technology
| | O: 1.76% H: 0.0% C: 0.0%

humira biosimilar approved for agreement
Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets
Published: 2024-04-16 (Crawled : 13:00) - biospace.com/
TEVA | $13.01 -0.68% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.23% H: 0.23% C: -1.28%

austedo for meeting
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
Published: 2024-04-11 (Crawled : 23:00) - biospace.com/
TEVA | $13.01 -0.68% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: -1.01% H: 2.04% C: 1.17%

ajovy for teva trial migraine china results
Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
Published: 2024-04-04 (Crawled : 00:00) - biospace.com/
TEVA | $13.01 -0.68% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.42% H: 0.0% C: 0.0%

candidate biosimilar global for teva agreement
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.